Transcatheter Aortic Valve Implantation: Current and Evolving Indications.
Transcatheter Aortic Valve Implantation (TAVI) was initially developed to treat aortic stenosis in patients with high risk for surgical intervention. With great initial adoption of the technology and improvements in device design and procedural success TAVI is increasingly being performed in broader populations for diverse indications. This paper is a concise review of the evolving and expanding use of TAVI in the current era.
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Altayyeb
A
Yousef
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Michael
M
Froeschl
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Benjamin
B
Hibbert
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ian G
IG
Burwash
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: mlabinaz@ottawaheart.ca.
Marino
M
Labinaz
D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000601:surgery*; D004867:Equipment Design; D006801:Humans; D012720:Severity of Illness Index; D065467:Transcatheter Aortic Valve Replacement / Q000295:instrumentation*; D016896:Treatment Outcome